Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation

Molecular Endocrinology
Rosemary SteinmetzOra Hirsch Pescovitz

Abstract

The ERK1/2 MAPK pathway is a critical signaling system that mediates ligand-stimulated signals for the induction of cell proliferation, differentiation, and cell survival. Studies have shown that this pathway is constitutively active in several human malignancies and may be involved in the pathogenesis of these tumors. In the present study we examined the ERK1/2 pathway in cell lines derived from epithelial and granulosa cell tumors, two distinct forms of ovarian cancer. We show that ERK1 and ERK2 are constitutively active and that this activation results from both MAPK kinase-dependent and independent mechanisms and is correlated with elevated BRAF expression. MAPK phosphatase 1 (MKP-1) expression, which is involved in ERK1/2 deactivation, is down-regulated in the cancer cells, thus further contributing to ERK hyperactivity in these cells. Treatment of these cancer cell lines with the proteasome inhibitor ZLLF-CHO increased MKP-1 but not MKP-2 expression and decreased ERK1/2 phosphorylation. More importantly, silencing of ERK1/2 protein expression using RNA interference led to the complete suppression of tumor cell proliferation. These results provide evidence that the ERK pathway plays a major role in ovarian cancer pathogene...Continue Reading

References

Aug 10, 1990·Science·J LyonsH R Bourne
Sep 21, 1989·The New England Journal of Medicine·R E LappöhnH W de Bruijn
Mar 1, 1995·Trends in Biochemical Sciences·E Cano, L C Mahadevan
May 1, 1995·American Journal of Obstetrics and Gynecology·C L BestJ A Hill
Jun 23, 1995·The Journal of Biological Chemistry·M H Cobb, E J Goldsmith
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·K A RismaJ H Nilson
Sep 22, 1994·The New England Journal of Medicine·M A RossingS G Self
Jan 10, 1997·The Journal of Biological Chemistry·J M BrondelloF R McKenzie
Apr 1, 1997·The Journal of Clinical Endocrinology and Metabolism·T J KotlarJ L Jameson
Apr 1, 1997·The Journal of Clinical Investigation·V S SivaramanC C Malbon
Aug 26, 1998·The Journal of Clinical Endocrinology and Metabolism·T KotlarJ L Jameson
Feb 13, 1999·American Journal of Obstetrics and Gynecology·H S CronjéJ D Woodruff
May 18, 1999·Gynecologic Oncology·P J FullerH G Burger
Aug 6, 1999·Clinical Endocrinology·D M RobertsonN Groome
Oct 16, 1999·The Journal of Clinical Endocrinology and Metabolism·S HusseinP J Fuller
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·R A KeriJ H Nilson
Apr 29, 2000·Gynecologic Oncology·J B GebhartK C Podratz
Jul 7, 2000·Seminars in Surgical Oncology·C H Holschneider, J S Berek
Apr 12, 2001·The Journal of Biological Chemistry·O P BarryG C O'Sullivan
Apr 9, 2002·Pediatric Hematology and Oncology·Laura Merras-SalmioMarkku Heikinheimo
Jun 5, 2002·Molecular and Cellular Endocrinology·Peter J FullerHenry G Burger
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Sep 6, 2002·Biochemical Pharmacology·Jacques PouysségurPhilippe Lenormand
Sep 10, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·D MayrJ Diebold

❮ Previous
Next ❯

Citations

Jul 26, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Keitaro YamaneHironobu Ihn
Dec 28, 2006·Apoptosis : an International Journal on Programmed Cell Death·Ingrid HerrMarkus W Büchler
Apr 16, 2013·Nature Structural & Molecular Biology·Kin Man SuenJohn E Ladbury
Mar 8, 2012·DNA and Cell Biology·Ani MaZiping Zhang
Mar 27, 2009·Anti-cancer Drugs·Rabindranath ChakrabartiGérald J Prud'homme
Dec 30, 2011·The Journal of Pharmacology and Experimental Therapeutics·Prabodh K KandalaSanjay K Srivastava
Nov 10, 2010·BMC Cancer·Shuangmei YeShixuan Wang
Jun 15, 2011·Drugs·Roshni KalachandMaurie Markman
Jan 10, 2013·Current Oncology·Z Rao, Y Ding
Jan 28, 2014·Journal of Molecular Endocrinology·Noora AnderssonMarkku Heikinheimo
Nov 25, 2014·Molecular Carcinogenesis·Geetika SethiAndrew K Godwin
Sep 16, 2010·Free Radical Biology & Medicine·Simone ReuterBharat B Aggarwal
Jun 24, 2008·Biochemical and Biophysical Research Communications·William Ka Kei WuChi Hin Cho
Jan 15, 2014·The Journal of General Virology·María Eugenia RodríguezViviana Castilla
Aug 12, 2009·Biochimica Et Biophysica Acta·M HowlettA S Giraud
Mar 17, 2009·Biochemical and Biophysical Research Communications·Fengfeng LiBingfang Zeng
Jul 5, 2016·Frontiers in Cell and Developmental Biology·Roser BuscàPhilippe Lenormand
Nov 5, 2016·Clinical Genetics·P J FullerS Chu
Apr 15, 2006·Journal of Lipid Research·Atsuyoshi NishinaShoei Furukawa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.